River Street Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Sell
529
-70
-12% -$33.6K 0.08% 152
2026
Q1
$294K Buy
599
+55
+10% +$29.8K 0.1% 144
2025
Q4
$315K Hold
544
0.12% 125
2025
Q3
$264K Sell
544
-10
-2% -$4.66K 0.1% 137
2025
Q2
$225K Buy
554
+3
+0.5% +$1.25K 0.1% 141
2025
Q1
$274K Hold
551
0.14% 119
2024
Q4
$287K Hold
551
0.15% 118
2024
Q3
$341K Hold
551
0.19% 117
2024
Q2
$305K Buy
551
+28
+5% +$16K 0.19% 119
2024
Q1
$304K Hold
523
0.21% 105
2023
Q4
$278K Sell
523
-41
-7% -$19.8K 0.22% 103
2023
Q3
$285K Buy
564
+82
+17% +$43.7K 0.27% 93
2023
Q2
$251K Hold
482
0.24% 102
2023
Q1
$278K Hold
482
0.27% 97
2022
Q4
$265K Buy
+482
New +$255K 0.28% 97

Other funds holding TMO

River Street Advisors's TMO Position: Q2 2026 in Review

River Street Advisors reduced its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, selling an estimated $33.6K and leaving 529 shares worth $265K. The position accounts for 0.08% of the portfolio, ranked #152.

River Street Advisors first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $341K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • River Street Advisors held 529 shares of Thermo Fisher Scientific worth $265K as of Q2 2026.
  • River Street Advisors sold 70 Thermo Fisher Scientific shares in Q2 2026, an estimated $33.6K.
  • Thermo Fisher Scientific made up 0.08% of River Street Advisors's portfolio in Q2 2026, its #152 holding.
  • River Street Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • River Street Advisors's Thermo Fisher Scientific position peaked at $341K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on River Street Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.